Jakafi 20 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FDK54
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,180
Award facts
- Contract value 100% obligated
- $24,179.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $24.2K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a direct fulfillment of pharmaceutical supply needs for military healthcare facilities. The award includes no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established status as a woman-owned small business enterprise registered in the System for Award Management (SAM) since 2001.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500M single-award vehicle valid through November 2026 that enables the agency to procure an extensive portfolio of pharmaceutical products including prescription medications, biologics, and medical consumables. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic drugs, specialty medications, and medical products to Department of Defense healthcare sites nationwide. The compressed performance timeline reflects the urgent nature of pharmaceutical supply requirements for military medical operations.
Quick answers
Who was awarded contract SPE2DB25FDK54?
SPE2DB25FDK54 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FDK54 worth?
The government has obligated $24,180 on SPE2DB25FDK54.
Is contract SPE2DB25FDK54 an order under another contract?
Yes. SPE2DB25FDK54 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK54 competed?
The extent of competition for SPE2DB25FDK54 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award